The Cooper Companies, Inc. (NASDAQ:COO) Shares Acquired by Northern Trust Corp

Northern Trust Corp grew its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 15.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,018,898 shares of the medical device company's stock after buying an additional 268,972 shares during the quarter. Northern Trust Corp owned about 1.01% of Cooper Companies worth $185,597,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of COO. Byrne Asset Management LLC purchased a new stake in shares of Cooper Companies during the 4th quarter worth $33,000. OFI Invest Asset Management acquired a new position in Cooper Companies during the fourth quarter worth about $34,000. New Age Alpha Advisors LLC purchased a new position in Cooper Companies in the fourth quarter valued at about $38,000. Covestor Ltd lifted its position in shares of Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after acquiring an additional 120 shares during the period. Finally, West Financial Advisors LLC purchased a new stake in shares of Cooper Companies during the 4th quarter worth approximately $49,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Trading Up 1.4 %

Shares of COO stock traded up $1.16 during trading hours on Friday, hitting $82.30. 1,708,555 shares of the company were exchanged, compared to its average volume of 1,432,746. The firm has a fifty day moving average of $81.44 and a 200 day moving average of $91.69. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 1 year low of $69.81 and a 1 year high of $112.38. The firm has a market cap of $16.46 billion, a PE ratio of 42.21, a PEG ratio of 2.25 and a beta of 1.08.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.92. The company had revenue of $964.70 million during the quarter, compared to analysts' expectations of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research firms have commented on COO. Citigroup decreased their target price on Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. Robert W. Baird lowered their price objective on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a research note on Friday, March 7th. Stifel Nicolaus cut their target price on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a research report on Friday, March 7th. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a research report on Friday, March 7th. Finally, JPMorgan Chase & Co. cut their price objective on Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Friday, March 7th. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $110.25.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.